Steffen Schneider

Further involvements

• 08/03/2023

  10:15 – 10:30 10 Min. 5 Min.

  • Oral presentation
  • 51

  Pre-operative medication assessment and optimization to improve clinical outcomes of women with ovarian cancer: subproject of the prospective KORE-INNOVATION trial.

   Pharmacoepidemiology and drug safety
• 08/03/2023

  • Poster
  • P127

  Assessment of the performance of a New Approach Method (NAM) testing DIO1 inhibition using a human microsome based, colorimetric assay

   Nuclear receptors, enzymes and other targets , Toxicological methods and in vitro toxicology